RXRX vs MESO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

RXRX

37.9
AI Score
VS
MESO Wins

MESO

62.3
AI Score

Investment Advisor Scores

RXRX

38score
Recommendation
AVOID NEW MONEY

MESO

62score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric RXRX MESO Winner
Forward P/E 0 454.5455 Tie
PEG Ratio 0 0 Tie
Revenue Growth -60.1% 390.7% MESO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 37.9/100 62.3/100 MESO
Profit Margin 0.0% -47.8% RXRX
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD MESO

Relative Price Performance (Last 90 Days)

RXRX 1M: +20.6% · 3M: +2.9% MESO 1M: -18.5% · 3M: -1.7%

Current Technical Phase

RXRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.9% over 20 days), RSI 61

RSI (14): 61.1 · Price: $4.08

MESO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.5%), weak momentum, RSI 38

RSI (14): 37.7 · Price: $14.09

Fundamentals Snapshot

Metric RXRX MESO
Market Cap — —
Forward P/E -4.5 -238.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.6% 3.9%
Gross Margin -7.2% 0.8%
Operating Margin -17.6% -0.3%
EPS -1.02 -0.44
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MESO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.